SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific (BSX) Any Comments???
BSX 94.71-0.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike who wrote (728)3/20/2000 9:09:00 AM
From: Lighthouse  Read Replies (1) of 798
 
My two cents:

In regards to the stent lineup you are correct the ship is still taking on water IMHO. The "Sox" is o.k. but will not materially alter market share gains. Gold-stiff Nir Royal means tough sledding ahead. Tobin is still trying to sort out the relationship with Medinol and in the meantime is trying to use some COGS savings to smooth over the EPS targets. He is playing the hand dealt to him well - it is just that the hand was worse than anyone thought.

I am more encouraged on the management front. Several new and good hires have rounded out the upper management ranks. BSX has a deeper bench of executives today than it ever had in the past. This is very good news long term. Short term no difference.

Cheers,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext